Article Text

Download PDFPDF
Original research
The relationship between corticospinal excitability and structural integrity in stroke patients
  1. Lina Daghsen1,2,
  2. Thomas Checkouri1,2,
  3. Aymric Wittwer2,3,
  4. Romain Valabregue1,4,
  5. Damien Galanaud1,4,5,
  6. François-Xavier Lejeune1,6,
  7. Mohammed Doulazmi7,
  8. Jean-Charles Lamy1,4,
  9. Pierre Pouget1,
  10. Emmanuel Roze1,8,
  11. Charlotte Rosso1,2,3
  1. 1Institut du Cerveau, ICM, Inserm U1127, CNRS UMR 7225, Sorbonne Université, Paris 75013, France
  2. 2STARE team, iCRIN, Institut du Cerveau ICM, Paris, France
  3. 3AP-HP, Urgences Cérébro-Vasculaires, DMU Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France
  4. 4CENIR, Institut du Cerveau ICM, Paris, France
  5. 5AP-HP, Service de Neuroradiologie, Hôpital Pitié-Salpêtrière, Paris, France
  6. 6Data Analysis Core, Institut du Cerveau ICM, Paris, France
  7. 7Sorbonne Université, CNRS, INSERM, Institut de Biologie Paris-Seine (IBPS), Adaptation Biologique et Vieillissement, Paris, France
  8. 8AP-HP, Département des Maladies du Système Nerveux, Hôpital Pitié-Salpêtrière, Paris, France
  1. Correspondence to Pr Charlotte Rosso; charlotte.rosso{at}gmail.com

Abstract

Background Evaluation of the structural integrity and functional excitability of the corticospinal tract (CST) is likely to be important in predicting motor recovery after stroke. Previous reports are inconsistent regarding a possible link between CST structure and CST function in this setting. This study aims to investigate the structure‒function relationship of the CST at the acute phase of stroke (<7 days).

Methods We enrolled 70 patients who had an acute ischaemic stroke with unilateral upper extremity (UE) weakness. They underwent a multimodal assessment including clinical severity (UE Fugl Meyer at day 7 and 3 months), MRI to evaluate the CST lesion load and transcranial magnetic stimulation to measure the maximum amplitude of motor evoked potential (MEP).

Results A cross-sectional lesion load above 87% predicted the absence of MEPs with an accuracy of 80.4%. In MEP-positive patients, the CST structure/function relationship was bimodal with a switch from a linear relationship (rho=−0.600, 95% CI −0.873; −0.039, p<0.03) for small MEP amplitudes (<0.703 mV) to a non-linear relationship for higher MEP amplitudes (p=0.72). In MEP-positive patients, recovery correlated with initial severity. In patients with a positive MEP <0.703 mV but not in patients with an MEP ≥0.703 mV, MEP amplitude was an additional independent predictor of recovery. In MEP-negative patients, we failed to identify any factor predicting recovery.

Conclusion This large multimodal study on the structure/function of the CST and stroke recovery proposes a paradigm change for the MEP-positive patients phenotypes and refines the nature of the link between structural integrity and neurophysiological function, with implications for study design and prognostic information.

  • stroke
  • recovery
  • motor evoked potential
  • corticospinal tract

Data availability statement

Data are available upon reasonable request. Request of our data necessitate specific local ethic committee approval and to follow GDPR rules.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request. Request of our data necessitate specific local ethic committee approval and to follow GDPR rules.

View Full Text

Footnotes

  • Contributors LD: data collection and analysis and drafting of manuscript. CR: study design, data analysis and drafting of manuscript. ER and PP: study design, drafting and revision of the manuscript. J-CL: data collection and manuscript revision. TC, AW, RV and DG: data collection and data analysis. F-XL and MD: statistical analysis.

    CR acted as the guarantor for the integrity of the work.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.